Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Modular Medical, Inc. (Nasdaq: MODD) announced that its CEO, Jeb Besser, will present at Tribe Public's webinar "From FDA Wins to Scaling Manufacturing - What Investors Should Watch" on Friday, May 1, 2026. The event will focus on Modular Medical's newly FDA-cleared Pivot insulin patch pump, designed to make insulin delivery more accessible and affordable for the 4.8 million Americans with diabetes. Investors are encouraged to register to learn about the company's commercial and manufacturing timelines, as well as its strategy to target the large underserved market of individuals currently using multiple daily injections.
How this was made
The 30-second read
Why it matters
The upcoming webinar featuring the CEO is expected to boost investor confidence and stock price, contingent on company updates and market reception.
Market read
The event is highly relevant for investors interested in medical devices and diabetes care sectors, with potential short-term trading opportunities.
What to watch
Potential delays in manufacturing ramp-up or market adoption could temper stock performance.
Background
Modular Medical received FDA clearance for its Pivot insulin patch pump, addressing a large underserved diabetic population.
Ticker impact
High relevance due to recent FDA clearance and upcoming investor webinar.
Moderate upward movement within the next 1-2 weeks.
FDA clearance and strategic communication typically boost investor confidence, especially given the company's focus on an underserved market segment.
Market effects
Positive impact on the medical device and life sciences sectors, especially companies targeting diabetes management.
Likely to influence US-based healthcare and biotech markets.
Moderate, as the primary focus is on US market and regulatory approval.
Counterpoint
Market may have already priced in FDA approval; the webinar may not lead to significant further gains.
Key entities
- CompanyModular Medical, Inc.
Developer of innovative insulin delivery devices.
- CEOJeb Besser
Chief Executive Officer of Modular Medical.
